Figure 3: The use of PDC*vac platform to develop NeoAg-based cancer vaccines.
Credit
2023 Hannani et al.
Usage Restrictions
Original Content
License
Original content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.